Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

Delayed Data
As of Nov 24
 +0.12 / +0.20%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Endo International plc is a global specialty healthcare company, which focuses on improving patients' lives while creating value. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices through its operating companies: Endo Pharmaceuticals, Qualitest, AMS, Paladin Labs and SOMAR. Endo Pharmaceuticals is focused on developing and delivering high-value branded products that meet the unmet needs of patients. American Medical Systems (AMS) is a diversified supplier of medical devices and procedures to treat incontinence, sexual dysfunction, benign prostatic hyperplasia (BPH), and other pelvic disorders in men and women. Qualitest provides affordable generic pharmaceuticals. Paladin Labs is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. SOMAR is a leading pharmaceutical company focused on the development, manufacturing, marketing and commercialization of high-quality products across key market segments in Mexico. Endo International was founded on October 31, 2013 and is headquartered Dublin, Ireland.

Contact Information

Endo International Plc
Minerva House
Dublin Dublin 2
P:(531) 268-2000
Investor Relations:



Mutual fund holders49.64%
Other institutional45.39%
Individual stakeholders0.56%

Top Executives

Rajiv De SilvaPresident, Chief Executive Officer & Director
Robert J. CobuzziSVP-Operations, Research & Development Strategy
Suketu P. UpadhyayChief Financial Officer & Executive Vice President
Susan T. HallChief Scientific Officer & Executive VP
Craig PatersonChief Medical Officer